Optogenetic control of reward-related behaviors

K Deisseroth, I Witten - US Patent 9,992,981, 2018 - Google Patents
Provided herein are compositions and methods for disrupting at least one reward-related
behavior in an individual through the use of light-responsive opsin proteins used to control …

Potential molecular targets in the treatment of lung cancer using siRNA technology

H Zarredar, K Ansarin, B Baradaran… - Cancer …, 2018 - Taylor & Francis
Lung cancer is the leading cause of cancer-related mortality with about 1.6 million deaths
every year worldwide. Gene mutations and overexpression of oncogenes play a central role …

System, method and applications involving identification of biological circuits such as neurological characteristics

K Deisseroth, RD Airan, LA Meltzer - US Patent 9,693,692, 2017 - Google Patents
Various aspects are directed to systems and methods for assessing neural activity of a
neural region having multiple subfields. In certain embodiments, a method includes evoking …

Thermoresponsive pegylated bubble liposome nanovectors for efficient siRNA delivery via endosomal escape

K Alamoudi, P Martins, JG Croissant, S Patil… - …, 2017 - Future Medicine
Aim: Improving the delivery of siRNA into cancer cells via bubble liposomes. Designing a
thermoresponsive pegylated liposome through the introduction of ammonium bicarbonate …

Gene therapy using plasmid DNA-encoded anti-HER2 antibody for cancers that overexpress HER2

H Kim, SN Danishmalik, H Hwang, JI Sin, J Oh… - Cancer Gene …, 2016 - nature.com
Plasmid DNA-encoded antibodies, or DNA-based monoclonal antibodies (dMAbs), are
delivered by intramuscular injection and in vivo electroporation (EP) and are effective in …

CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia

U Gamage, K Warnakulasuriya, S Hansika… - Thalassemia …, 2023 - mdpi.com
β-Thalassemia is an inherited hematological disorder that results from genetic changes in
the β-globin gene, leading to the reduced or absent synthesis of β-globin. For several …

Gene therapy research in Asia

HX Deng, Y Wang, QR Ding, DL Li, Y Wei - Gene therapy, 2017 - nature.com
Gene therapy has shown great potential for the treatment of diseases that previously were
either untreatable or treatable but not curable with conventional schemes. Recent progress …

Magnetofection mediated transient NANOG overexpression enhances proliferation and myogenic differentiation of human hair follicle derived mesenchymal stem cells

S Son, MS Liang, P Lei, X Xue, EP Furlani… - Bioconjugate …, 2015 - ACS Publications
We used magnetofection (MF) to achieve high transfection efficiency into human
mesenchymal stem cells (MSCs). A custom-made magnet array, matching well-to-well to a …

Protection is not always a good thing: The immune system's impact on gene therapy

MV Freitas, L Frâncio, L Haleva… - Genetics and molecular …, 2022 - SciELO Brasil
There are many clinical trials underway for the development of gene therapies, and some
have resulted in gene therapy products being commercially approved already. Significant …

scAAV2-Mediated Expression of Thioredoxin 2 and C3 Transferase Prevents Retinal Ganglion Cell Death and Lowers Intraocular Pressure in a Mouse Model of …

HJ Kim, S Cha, JS Choi, JY Lee, KE Kim… - International Journal of …, 2023 - mdpi.com
Elevated intraocular pressure (IOP) in glaucoma causes retinal ganglion cell (RGC) loss and
damage to the optic nerve. Although IOP is controlled pharmacologically, no treatment is …